(PharmaNewsWire.Com, April 18, 2019 ) Musculoskeletal diseases treatment market is segmented by diseases and imaging modality. On the basis of diseases, the market is segmented into arthritis, osteoarthritis, osteoporosis, spondylitis, and other. The imaging modality segment of the musculoskeletal diseases treatment market is segmented into computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and others. The global musculoskeletal diseases treatment market is expected to reach US$ 5,730.8 Mn in 2025 from US$ 3,837.9 in 2017. The musculoskeletal diseases treatment market is estimated to grow with a CAGR of 5.3% from 2018-2025.
Musculoskeletal disorders (MSDs) are conditions that can affect your muscles, bones, and joints. The severity of MSDs can vary according to the patient. They cause pain and discomfort that interferes with everyday activities. Early diagnosis and treatment may help ease symptoms and improve the lifestyle. The doctor order imaging tests, such as X-rays or MRI scans. These tests can help them examine the bones and soft tissues. The report would be of an interest to various stakeholders operating in the musculoskeletal diseases treatment market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research and consulting firms.
The Major Key Market Players: General Electric Koninklijke Philips N.V Siemens AG Canon Medical Systems Corporation Hitachi, Ltd
The objective of the study is to describe, define, and forecast the musculoskeletal diseases treatment market by diseases and imaging modality and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.
The report analyzes factors affecting musculoskeletal diseases treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key musculoskeletal diseases treatment manufacturing companies along with their SWOT analysis and market strategies.
The major players operating in the musculoskeletal diseases treatment market include General Electric, Koninklijke Philips N.V., Siemens AG, Canon Medical Systems Corporation, Hitachi, Ltd., Accuray Incorporated, MR Solutions, Alltech Medical Systems, Terason Division Teratech Corporation, and Echo-Son SA. For instance, in July 2018, Siemens Healthineers launched the new Acuson Sequoia, the ultrasound system. The products has features as it produces penetration up to 40cm, its Deep Abdominal Transducer (DAX), a new high-powered architecture, and updates to elastography and contrast-enhanced ultrasound. And the launch expanded the geographical presence of the company in global musculoskeletal diseases treatment market.
Reason to Buy: - Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Musculoskeletal Diseases Treatment Market - Highlights key business priorities in order to assist companies to realign their business strategies. - The key findings and recommendations highlight crucial progressive industry trends in the Musculoskeletal Diseases Treatment Market, thereby allowing players to develop effective long term strategies. - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. - Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
About The Insight Partners The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, and Telecommunication industries.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
